| Dr Elizabeth K Donohue, MD | |
|
9155 Sw Barnes Rd, Ste 430, Portland, OR 97225-6625 | |
| (503) 297-4718 | |
| (503) 292-4496 |
| Full Name | Dr Elizabeth K Donohue |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 34 Years |
| Location | 9155 Sw Barnes Rd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316941917 | NPI | - | NPPES |
| 136172 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD21142 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Eye Clinic Pc | 7719972736 | 3 |
News Archive
Imagine developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic. This was the dilemma faced by scientists researching inhibitors of signal transducer and activator of transcription (STAT3), a protein that controls transcription by the STAT3 gene.
Researchers at the University of Illinois at Chicago were able to reduce uncertainty in diagnosing cardiac sarcoidosis by having patients consume a high-fat, low-sugar diet for 72 hours prior to diagnostic imaging.
Inadequate use of screening mammography may be an important reason that African-American women are more likely to be diagnosed with advanced stage breast cancer than members of other ethnic groups, according to a new study led by a University of California, San Francisco imaging specialist.
Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical swelling in spinal fusion procedures, a problem that prompted an FDA warning in 2008.
Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.
› Verified 2 days ago
| Entity Name | The Eye Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639247885 PECOS PAC ID: 7719972736 Enrollment ID: O20040419001142 |
News Archive
Imagine developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic. This was the dilemma faced by scientists researching inhibitors of signal transducer and activator of transcription (STAT3), a protein that controls transcription by the STAT3 gene.
Researchers at the University of Illinois at Chicago were able to reduce uncertainty in diagnosing cardiac sarcoidosis by having patients consume a high-fat, low-sugar diet for 72 hours prior to diagnostic imaging.
Inadequate use of screening mammography may be an important reason that African-American women are more likely to be diagnosed with advanced stage breast cancer than members of other ethnic groups, according to a new study led by a University of California, San Francisco imaging specialist.
Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical swelling in spinal fusion procedures, a problem that prompted an FDA warning in 2008.
Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth K Donohue, MD 9155 Sw Barnes Rd, Ste 430, Portland, OR 97225-6625 Ph: (503) 297-4718 | Dr Elizabeth K Donohue, MD 9155 Sw Barnes Rd, Ste 430, Portland, OR 97225-6625 Ph: (503) 297-4718 |
News Archive
Imagine developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic. This was the dilemma faced by scientists researching inhibitors of signal transducer and activator of transcription (STAT3), a protein that controls transcription by the STAT3 gene.
Researchers at the University of Illinois at Chicago were able to reduce uncertainty in diagnosing cardiac sarcoidosis by having patients consume a high-fat, low-sugar diet for 72 hours prior to diagnostic imaging.
Inadequate use of screening mammography may be an important reason that African-American women are more likely to be diagnosed with advanced stage breast cancer than members of other ethnic groups, according to a new study led by a University of California, San Francisco imaging specialist.
Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical swelling in spinal fusion procedures, a problem that prompted an FDA warning in 2008.
Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.
› Verified 2 days ago
Amy Ying Tong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 Nw Northrup St, Portland, OR 97209 Phone: 503-227-2020 | |
Sungjae Yang, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3375 Sw Terwilliger Bld, Casey Eye Institue, Portland, OR 97239 Phone: 503-494-5023 | |
Dr. Michael David Straiko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1040 Nw 22nd Ave., Suite 200, Portland, OR 97210 Phone: 503-413-8202 Fax: 503-413-6937 | |
Allison Rebecca Loh, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3375 Sw Terwilliger Blvd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
John Carl Morrison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-418-0843 | |
Adam Marcus Hanif, Ophthalmology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
Mr. John Jah-hyun Koo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 N. Interstate Avenue, Department Of Opthalmology, Portland, OR 97227 Phone: 503-331-6330 Fax: 503-571-5877 |